Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation

Akram M Zaaqoq1, Matthew J Griffee2, Thu-Lan Kelly3

  • 1Department of Critical Care Medicine, MedStar Washington Hospital Center, Georgetown University, Washington, DC.

Insights

Obesity and pre-extracorporeal membrane oxygenation (ECMO) vasopressor use increase stroke risk in COVID-19 patients on venovenous ECMO. Changes in carbon dioxide and oxygen levels post-ECMO also indicate higher stroke risk and mortality.

Area of Science:

  • Critical care medicine
  • Neurology
  • Infectious diseases

Background:

  • Cerebrovascular complications in COVID-19 patients requiring venovenous extracorporeal membrane oxygenation (ECMO) are not well-characterized.
  • Understanding stroke prevalence and risk factors in this population is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the prevalence and identify risk factors for stroke in adult COVID-19 patients supported by venovenous ECMO.
  • To analyze the association between pre-ECMO and early post-ECMO physiological parameters and stroke development.

Main Methods:

  • Analysis of prospectively collected data from the COVID-19 Critical Care Consortium (COVID Critical) registry.
  • Inclusion of 595 adult COVID-19 patients on venovenous ECMO.
  • Utilized univariable and multivariable survival modeling (Cox proportional hazards and Fine-Gray models) with competing risks.

Main Results:

  • Stroke occurred in 7.2% of patients, with 83.7% being hemorrhagic.
  • Obesity (aHR, 2.19) and pre-ECMO vasopressor use (aHR, 2.37) were significantly associated with increased stroke risk.
  • Stroke patients exhibited greater relative decreases in PaCO2 and moderate increases in PaO2 within 48 hours of ECMO initiation.
  • In-hospital mortality was substantially higher in patients who experienced stroke (79%) compared to those who did not (45%).

Conclusions:

  • Obesity and pre-ECMO vasopressor use are significant risk factors for stroke in COVID-19 patients on venovenous ECMO.
  • Specific changes in PaCO2 and PaO2 within 48 hours of ECMO initiation are associated with stroke development.
  • Stroke in this population portends a significantly worse prognosis, underscoring the need for vigilant monitoring and management.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
45
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
13
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
54
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
14
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
18
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
18